T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Apple
AAPL
|
+$4.53B |
| 2 |
Broadcom
AVGO
|
+$1.7B |
| 3 |
GE Vernova
GEV
|
+$1.29B |
| 4 |
International Paper
IP
|
+$1.11B |
| 5 |
Tesla
TSLA
|
+$956M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.44B |
| 2 |
NVIDIA
NVDA
|
+$2.09B |
| 3 |
Constellation Energy
CEG
|
+$1.9B |
| 4 |
Qualcomm
QCOM
|
+$1.84B |
| 5 |
Amazon
AMZN
|
+$1.56B |
Sector Composition
| 1 | Technology | 34% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Communication Services | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
CG Oncology
CGON
$2.73B
| $21M | ﹤0.01% |
665,145
-326,973
| -33% | -$10.3M |
|
952
Masco
MAS
$15.4B
| $21M | ﹤0.01% |
314,425
-12,661
| -4% | -$844K |
|
953
BridgeBio Pharma
BBIO
$9.84B
| $20.9M | ﹤0.01% |
824,818
+20,862
| +3% | +$528K |
|
954
Elastic
ESTC
$9.38B
| $20.3M | ﹤0.01% |
178,230
-51,112
| -22% | -$5.82M |
|
955
ServisFirst Bancshares
SFBS
$4.58B
| $20.2M | ﹤0.01% |
319,760
-6,036
| -2% | -$381K |
|
956
Reddit
RDDT
$49.3B
| $19.9M | ﹤0.01% |
312,148
-438,348
| -58% | -$28M |
|
957
MarketAxess Holdings
MKTX
$6.79B
| $19.9M | ﹤0.01% |
99,403
-48,953
| -33% | -$9.82M |
|
958
Laureate Education
LAUR
$4.35B
| $19.9M | ﹤0.01% |
1,332,164
+1,175,726
| +752% | +$17.6M |
|
959
Teleflex
TFX
$5.56B
| $19.7M | ﹤0.01% |
93,708
-1,230,454
| -93% | -$259M |
|
960
Trimble
TRMB
$19.3B
| $19.7M | ﹤0.01% |
351,371
+6,629
| +2% | +$371K |
|
961
Gulfport Energy Corp
GPOR
$3.02B
| $19.6M | ﹤0.01% |
129,679
+111,679
| +620% | +$16.9M |
|
962
Tencent Music
TME
$39.3B
| $19.5M | ﹤0.01% |
1,387,649
-287,624
| -17% | -$4.04M |
|
963
Soleno Therapeutics
SLNO
$2.72B
| $19.5M | ﹤0.01% |
477,852
+325,232
| +213% | +$13.3M |
|
964
EPAM Systems
EPAM
$8.61B
| $19.4M | ﹤0.01% |
102,937
+1,498
| +1% | +$282K |
|
965
A.O. Smith
AOS
$10.3B
| $19.3M | ﹤0.01% |
235,683
+1,085
| +0.5% | +$88.7K |
|
966
Snap-on
SNA
$17.7B
| $19.2M | ﹤0.01% |
73,561
+1,038
| +1% | +$271K |
|
967
Healthpeak Properties
DOC
$12.7B
| $19.2M | ﹤0.01% |
977,290
+24,858
| +3% | +$487K |
|
968
Catalyst Pharmaceutical
CPRX
$2.42B
| $19.1M | ﹤0.01% |
1,232,852
+13,434
| +1% | +$208K |
|
969
Huazhu Hotels Group
HTHT
$11.3B
| $18.9M | ﹤0.01% |
568,305
+699
| +0.1% | +$23.3K |
|
970
Brunswick
BC
$4.27B
| $18.9M | ﹤0.01% |
259,050
-49,293
| -16% | -$3.59M |
|
971
Akamai
AKAM
$11B
| $18.8M | ﹤0.01% |
209,017
-91,502
| -30% | -$8.24M |
|
972
Veeco
VECO
$1.57B
| $18.8M | ﹤0.01% |
402,385
+374,122
| +1,324% | +$17.5M |
|
973
Virtus Investment Partners
VRTS
$1.31B
| $18.6M | ﹤0.01% |
82,261
+2,019
| +3% | +$456K |
|
974
A10 Networks
ATEN
$1.27B
| $18.6M | ﹤0.01% |
1,341,408
+98,616
| +8% | +$1.37M |
|
975
PTC Therapeutics
PTCT
$4.69B
| $18.6M | ﹤0.01% |
606,676
-33,191
| -5% | -$1.02M |
|